Former human services minister Michael Keenan is keeping a low profile. Or, at least, as low as possible, given a whole chapter is devoted to his conduct in the just-released robo-debt royal commission.
Imagine our surprise, then, to see him pop up on the ASX, having been appointed on Tuesday to the board of $12 million Singapore-based biotech Osteopore (as first noted by trade title Biotech Daily).
Loading...
Myriam Robin is a senior writer based in the Melbourne newsroom. She has previously been a Rear Window columnist and editor, and before that reported on financial markets and media. Connect with Myriam on Twitter. Email Myriam at myriam.robin@afr.com
